{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:16:11Z","timestamp":1783016171875,"version":"3.54.6"},"posted":{"date-parts":[[2024,3,7]]},"group-title":"Obstetrics and Gynecology","reference-count":37,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,3,7]]},"abstract":"<jats:sec>\n                  <jats:title>Capsule<\/jats:title>\n                  <jats:p>In this study the presence of uterine fibroids was significantly associated with an increased risk of development of hypertensive disorders of pregnancy even when accounting for age and BMI in meta-regression. This finding has potential implications for risk stratification and monitoring for hypertension during pregnancy in this population.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To examine the association between uterine fibroids and the development of hypertensive disorders in pregnancy.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Data sources<\/jats:title>\n                  <jats:p>Cochrane, Embase, PubMed, MEDLINE, Scopus, and Web of Science databases were searched from inception through April 2023.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Study Selection and Synthesis<\/jats:title>\n                  <jats:p>Cohort, case-control, or case series studies including uterine fibroid status and hypertensive disorders of pregnancy status were included. The comparison group was pregnant women without uterine fibroids. Inverse-variance weighted random effects models were used to pool RR and OR estimates separately. Age and BMI were explored as potential sources of heterogeneity using inverse-variance weighted meta-regression.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Main Outcomes<\/jats:title>\n                  <jats:p>Hypertensive disorders of pregnancy (HDP) defined as gestational hypertension, pre-eclampsia, eclampsia, superimposed preeclampsia, or hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 17 studies were included (Total N=1,374,395 participants, N=64,968 with uterine fibroids). Thirteen studies were retrospective cohorts and four were case-control studies. Women with uterine fibroids had a significantly higher risk of hypertensive disorders in pregnancy compared to women without uterine fibroids with RR 1.74 (95% CI 1.33-2.27, p&lt;0.01), and OR 2.87 (95% CI 1.38-5.97, p&lt;0.01), in cohort studies and case-control studies, respectively. In meta-regression analyses, age did not significantly change the positive association between uterine fibroids and hypertensive disorders in pregnancy.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Uterine fibroids were associated with an increased risk of hypertensive disorders of pregnancy when all available literature was synthesized, including when shared risk factors are examined in meta-regression analyses.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Relevance<\/jats:title>\n                  <jats:p>If confirmed in future studies, investigations into the mechanisms of this association are needed as this finding potentially has implications for risk stratification and monitoring for hypertensive disorders of pregnancy in this population.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Trial Registration<\/jats:title>\n                  <jats:p>PROSPERO, ID # 331528<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.03.05.24303824","type":"posted-content","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T14:45:19Z","timestamp":1709822719000},"source":"Crossref","is-referenced-by-count":3,"title":["Uterine Fibroids and Hypertensive Disorders in Pregnancy: A Systematic Review and Meta-Analysis"],"prefix":"10.64898","author":[{"given":"Susan","family":"Nasab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5265-7731","authenticated-orcid":false,"given":"Ethan K","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-6080","authenticated-orcid":false,"given":"Elisabeth","family":"Nylander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-132X","authenticated-orcid":false,"given":"Mostafa","family":"Borahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-376X","authenticated-orcid":false,"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-7339","authenticated-orcid":false,"given":"Valerie","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-0741","authenticated-orcid":false,"given":"Katherine","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"10","key":"2024030902250654000_2024.03.05.24303824v1.1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","year":"2017","journal-title":"BJOG"},{"issue":"6","key":"2024030902250654000_2024.03.05.24303824v1.2","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Gynecologists\u2019 Committee on Practice B-G. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228","volume":"137","author":"American College of O","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2024030902250654000_2024.03.05.24303824v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep320"},{"issue":"6","key":"2024030902250654000_2024.03.05.24303824v1.4","first-page":"829","article-title":"3rd, Diop H","volume":"226","year":"2022","journal-title":"Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts. Am J Obstet Gynecol"},{"issue":"2","key":"2024030902250654000_2024.03.05.24303824v1.5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.annepidem.2013.10.017","article-title":"Uterine leiomyomata and cesarean birth risk: a prospective cohort with standardized imaging","volume":"24","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"5","key":"2024030902250654000_2024.03.05.24303824v1.6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/AOG.0b013e3181f7496d","article-title":"Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes","volume":"116","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2024030902250654000_2024.03.05.24303824v1.7","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s43032-023-01215-x","article-title":"Relationship Among Surgical Fibroid Removal, Blood Pressure, and Biomarkers of Renin-Angiotensin-Aldosterone System Activation","volume":"30","year":"2023","journal-title":"Reprod Sci"},{"issue":"4","key":"2024030902250654000_2024.03.05.24303824v1.8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jch.13253","article-title":"The risk of hypertension and cardiovascular disease in women with uterine fibroids","volume":"20","year":"2018","journal-title":"J Clin Hypertens (Greenwich"},{"issue":"2","key":"2024030902250654000_2024.03.05.24303824v1.9","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/REP-21-0087","article-title":"Vascular biology of uterine fibroids: connecting fibroids and vascular disorders","volume":"162","year":"2021","journal-title":"Reproduction"},{"issue":"2","key":"2024030902250654000_2024.03.05.24303824v1.10","first-page":"e1039","article-title":"Uterine Fibroids and Hypertension: Steps Toward Understanding the Link","volume":"106","year":"2020","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2024030902250654000_2024.03.05.24303824v1.11","doi-asserted-by":"crossref","unstructured":"Miyashita-Ishiwata M , El Sabeh M , Reschke LD , Afrin S , Borahay MA . Differential response to hypoxia in leiomyoma and myometrial cells. Life Sci. 2022;290:120238.","DOI":"10.1016\/j.lfs.2021.120238"},{"key":"2024030902250654000_2024.03.05.24303824v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(99)00605-5"},{"issue":"4","key":"2024030902250654000_2024.03.05.24303824v1.13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10641955.2019.1667381","article-title":"Pre-existing medical disorders as risk factors for preeclampsia: an exploratory case-control study","volume":"38","year":"2019","journal-title":"Hypertens Pregnancy"},{"key":"2024030902250654000_2024.03.05.24303824v1.14","unstructured":"https:\/\/cran.r-project.org\/web\/packages\/metafor\/metafor.pdf."},{"key":"2024030902250654000_2024.03.05.24303824v1.15","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002729"},{"key":"2024030902250654000_2024.03.05.24303824v1.16","doi-asserted-by":"crossref","unstructured":"Gong L , Liu M , Shi H , Huang Y . Uterine fibroids are associated with increased risk of pre-eclampsia: A case-control study. Front Cardiovasc Med. 2022;9:1011311.","DOI":"10.3389\/fcvm.2022.1011311"},{"issue":"1","key":"2024030902250654000_2024.03.05.24303824v1.17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gocm.2023.01.008","article-title":"Influence of assisted reproductive technology and uterine leiomyoma on pregnancy outcomes in women with adenomyosis","volume":"3","year":"2023","journal-title":"Gynecology and Obstetrics Clinical Medicine"},{"issue":"3","key":"2024030902250654000_2024.03.05.24303824v1.18","first-page":"1183","article-title":"Potential risk factor of pre-eclampsia among healthy Chinese women: a retrospective case control study","volume":"28","year":"2017","journal-title":"Biomedical Research"},{"key":"2024030902250654000_2024.03.05.24303824v1.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187821"},{"issue":"12","key":"2024030902250654000_2024.03.05.24303824v1.20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jogc.2016.08.012","article-title":"Effect of Maternal Retroplacental Leiomyomas on Fetal Growth","volume":"38","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"2024030902250654000_2024.03.05.24303824v1.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1999.tb03442.x"},{"key":"2024030902250654000_2024.03.05.24303824v1.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-005-0738-y"},{"key":"2024030902250654000_2024.03.05.24303824v1.23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.earlhumdev.2019.01.004","article-title":"Perinatal outcome and long-term pediatric morbidity of pregnancies with a fibroid uterus","volume":"129","year":"2019","journal-title":"Early Hum Dev"},{"key":"2024030902250654000_2024.03.05.24303824v1.24","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2012.745504"},{"issue":"4","key":"2024030902250654000_2024.03.05.24303824v1.25","first-page":"410","article-title":"Leiomyomatous uterus and preterm birth: an exposed\/unexposed monocentric cohort study","volume":"219","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2024030902250654000_2024.03.05.24303824v1.26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12884-020-03406-9","article-title":"Nationwide population-based cohort study of adverse obstetric outcomes in pregnancies with myoma or following myomectomy: retrospective cohort study","volume":"20","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2024030902250654000_2024.03.05.24303824v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2020.08.006"},{"issue":"10","key":"2024030902250654000_2024.03.05.24303824v1.28","first-page":"e30740","article-title":"Cardiometabolic Risk and Cardiovascular Disease in Young Women With Uterine Fibroids","volume":"14","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"2024030902250654000_2024.03.05.24303824v1.29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ogc.2016.11.007","article-title":"Disparities in Fibroid Incidence, Prognosis, and Management","volume":"44","year":"2017","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2024030902250654000_2024.03.05.24303824v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew249"},{"key":"2024030902250654000_2024.03.05.24303824v1.31","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.103440"},{"key":"2024030902250654000_2024.03.05.24303824v1.32","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi072"},{"key":"2024030902250654000_2024.03.05.24303824v1.33","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000020689.12472.E0"},{"issue":"2","key":"2024030902250654000_2024.03.05.24303824v1.34","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1210\/clinem\/dgaa718","article-title":"Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women","volume":"106","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024030902250654000_2024.03.05.24303824v1.35","first-page":"750","article-title":"Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study","volume":"215","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"2024030902250654000_2024.03.05.24303824v1.36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/OGX.0000000000000718","article-title":"Cardiometabolic Risk Factors and Benign Gynecologic Disorders","volume":"74","year":"2019","journal-title":"Obstet Gynecol Surv"},{"issue":"7","key":"2024030902250654000_2024.03.05.24303824v1.37","first-page":"483","article-title":"Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis","volume":"41","year":"1996","journal-title":"J Reprod Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.03.05.24303824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:54:35Z","timestamp":1768506875000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.03.05.24303824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1101\/2024.03.05.24303824","relation":{},"subject":[],"published":{"date-parts":[[2024,3,7]]},"subtype":"preprint"}}